Larvol Delta - A-Dose-Escalation-and-Expansion-Trial-With-BYON4228-Alone-and-in-Combination-in-Patients-With-Advanced-or-Metastatic-Solid-Tumors

Keytruda (pembrolizumab) - Merck (MSD)

BYON4228 - Byondis

http://clinicaltrials.gov/ct2/show/NCT06932952

Apr 18, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next